TS

the SRIW Life Sciences

North America, Wisconsin, United States, Belgium

Description

the SRIW Life Sciences

Investor Profile

the SRIW Life Sciences has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A rounds (top funding stages).
  • Majority of deals are located in Belgium.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series B (67%)
  • Series A (33%)

Country Focus

  • Belgium (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Biopharma
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does the SRIW Life Sciences frequently co-invest with?

New Science Ventures
North America, Connecticut, United States, Greenwich
Co-Investments: 2
IB
Europe, Berlin, Germany, Berlin
Co-Investments: 1
Seventure Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
CL
Asia, Hong Kong Island, Hong Kong, Wan Chai
Co-Investments: 2
Fund+
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 2
Vives Louvain Technology Fund
Europe, Vlaams-Brabant, Belgium, Louvain-la-neuve
Co-Investments: 2
Investsud
Europe, Luxembourg, Belgium, Marche-en-famenne
Co-Investments: 2
N
Europe, Vlaams-Brabant, Belgium, Louvain-la-neuve
Co-Investments: 1

Which angels does the SRIW Life Sciences often collaborate with?

OV
Europe, Belgium
Shared Deals: 1
PD
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 2

What are some of recent deals done by the SRIW Life Sciences?

Novadip Biosciences

Mont-saint-guibert, Brabant Wallon, Belgium

Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.

BiotechnologyHealth CareMedicalTherapeutics
Series BNov 3, 2022
Amount Raised: $23,398,518
Novadip Biosciences

Mont-saint-guibert, Brabant Wallon, Belgium

Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.

BiotechnologyHealth CareMedicalTherapeutics
Series BOct 28, 2021
Amount Raised: $22,196,495
A-Mansia Biotech

Louvain-la-neuve, Vlaams-Brabant, Belgium

A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium.

BiopharmaBiotechnologyLife Science
Series AApr 27, 2018
Amount Raised: $15,790,497

Find More Investors Like the SRIW Life Sciences

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

the SRIW Life Sciences | Pipeseed